TXN2 and cancer: Its main mechanism of action is the inhibition of the reduction of Trx2 by thioredoxin reductase 2 [26,27,28], thereby defeating the ability of maintaining low intracellular reactive oxygen species (a key adaptation for cancer cell survival).